GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22804
Submission : 2009-05-07
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28081
Submission : 2014-02-26
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16662
Submission : 2003-06-25
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25332
Submission : 2011-09-16
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2151
Submission : 1973-09-06
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17589
Submission : 2004-08-06
Status : Inactive
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)
Drug : CREON
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 20725
Country : US
Patented : No
Drug : BIAXIN XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 50775
Country : US
Patented : No
Drug : BIAXIN
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 50698
Country : US
Patented : No
Drug : BIAXIN
Dosage Form : TABLET; ORAL
Application Number : 50662
Country : US
Patented : No
Drug : DULOXETINE HYDROCHLORIDE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 90776
Country : US
Patented : No

DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Drug : DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 202975
Country : US
Patented : No

Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 205761
Country : US
Patented : No

Drug : DOXYCYCLINE HYCLATE
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 200856
Country : US
Patented : No

Drug : ASPIRIN AND DIPYRIDAMOLE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 78804
Country : US
Patented : No

Drug : ASPIRIN AND DIPYRIDAMOLE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204552
Country : US
Patented : No

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 48.1
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 13.26
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 51.66
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 30
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 144.51
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 46.66
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 19.63
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 302.4
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 104.4
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
HYPROMELLOSE PHTHALATE
Route : ORAL
CAS : 9050-31-1
UNII : NA
Potency Amount : 45.36
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES